Expiration date: 09/2026

Chondrolonum - corrector metabolism of bone and cartilage tissue. The main action of the active substances included in Chondrolonum - restoration of cartilage surfaces of joints and the joint capsule, reducing pain and improving joint mobility.

FORM RELEASE

Lyophilized powder Chondrolonum for the preparation of sterile injectable solution in ampoules of 5 and 10 pieces in a cardboard box.

1 vial of lyophilized powder contains chondroitin sulfate, 100 mg.

Instructions for use of Chondrolonum annotation in each pack.

DESCRIPTION

Chondrolonum - a drug that can influence the exchange processes in hyaline cartilage to reduce degenerative changes, stimulate the biosynthesis of glycosaminoglycans.

While taking the drug reduces pain and improves the mobility of the already affected joints. In the treatment of joint degenerative changes with progressivemarine synovitis, the therapeutic effect is observed after 2 weeks since the introduction of the drug. Disappear manifestations of reactive synovitis, decreases pain, increases range of motion. After discontinuation of the drug its effect persists for a long period.

INDICATIONS

Degenerative diseases of joints and spine - the main indications for presentiation, such as:

Intervertebral osteochondrosis

Arthropathy

Osteoarthritis etc.

CONTRAINDICATIONS

The main contraindications of Chondrolonum associated with bleeding disorders:

Thrombophlebitis

A tendency to bleed

In addition, the drug is not prescribed to patients with Allergy to the drug components.

SIDE EFFECTS

Side effects of Chondrolonum: bleeding at the injection site, allergic reactions.

OVERDOSE

No cases of overdose were noted.

APPLICATION

The drug is administered intramuscularly 1 ampoule (100 mg) dissolved in 1 ml of water for injection, every other day. If portability Chondrolonum good, the dosage was increased to 2 ampoules (200 mg), starting with the fourth injection. The course of treatment – up to 30 injections. For appointment of repeated courses of therapy have to be coordinated with the attending physician.

SPECIAL INSTRUCTIONS

Data security the application of Chondrolonum during pregnancy and breastfeeding are not available, so for these conditions the drug is assigned with caution or not assigned at all.

Is released from pharmacies by prescription.

Shelf life: 3 years.